M. Kurtuncu Et Al. , "Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients," 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , Copenhagen, Denmark, pp.450, 2013
Kurtuncu, M. Et Al. 2013. Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , (Copenhagen, Denmark), 450.
Kurtuncu, M., Tuzun, E., Petek-Balci, B., Birday, E., Coban, A., Turkoglu, R., ... Icoz, S.(2013). Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients . 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS (pp.450). Copenhagen, Denmark
Kurtuncu, Murat Et Al. "Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients," 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2013
Kurtuncu, Murat Et Al. "Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients." 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , Copenhagen, Denmark, pp.450, 2013
Kurtuncu, M. Et Al. (2013) . "Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients." 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , Copenhagen, Denmark, p.450.
@conferencepaper{conferencepaper, author={Murat KÜRTÜNCÜ Et Al. }, title={Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients}, congress name={29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS}, city={Copenhagen}, country={Denmark}, year={2013}, pages={450} }